ELOXX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events.

On May 27, 2021, Eloxx Pharmaceuticals, Inc. (the "Company") issued a press release announcing the receipt of an award of up to $2.6M from the Cystic Fibrosis Foundation to help identify optimized oral RMAs for further development in the treatment of cystic fibrosis patients with nonsense mutations. A copy of the Company's press release is being furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



  99.1       Press Release dated May 27, 2021.
104        Inline XBRL for the cover page of this Current Report on Form 8-K

© Edgar Online, source Glimpses